Magnus Grenegård Selected Research

Magnus Grenegård Research Topics

3	ST Elevation Myocardial Infarction 01/2022 - 01/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 08/2005
2	Inflammation (Inflammations) 08/2022 - 10/2009
1	Heart Failure 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Carotid Artery Diseases 01/2020
1	Ischemic Stroke 08/2019
1	Myocardial Infarction 08/2019
1	Heart Diseases (Heart Disease) 01/2019
1	Atherosclerosis 01/2019
1	Hypertension (High Blood Pressure) 07/2014
1	Infections 07/2014
1	Thrombasthenia (Glanzmann Thrombasthenia) 02/2014

3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
1	InflammasomesIBA 08/2022
1	purineIBA 08/2022
1	Proteins (Proteins, Gene)FDA Link 08/2022
1	C-Reactive ProteinIBA 01/2022
1	Neprilysin (Neutral Endopeptidase)IBA 01/2022
1	asparaginylendopeptidase (legumain)IBA 01/2020
1	Cysteine Proteases (Cysteine Protease)IBA 01/2020
1	Pharmaceutical PreparationsIBA 08/2019
1	Purinergic P2Y Receptor AntagonistsIBA 08/2019
1	CathepsinsIBA 01/2019
1	cathepsin SIBA 01/2019
1	Thrombospondin 1IBA 01/2019
1	procaine isothiocyanate (PRIT)IBA 01/2019
1	Polysaccharides (Glycans)IBA 07/2014
1	fucoidanIBA 07/2014
1	IntegrinsIBA 02/2014
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2009
1	Orosomucoid (Seromucoid)IBA 10/2009
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2007
1	oxidized low density lipoproteinIBA 08/2005

2	Percutaneous Coronary Intervention 01/2022 - 01/2020